Autologous Mesenchymal Stromal Cells and Kidney Transplantation
Article 2010 en
Authors
NP
Norberto Perico
FC
Federica Casiraghi
MI
Martino Introna
Abstract
1 min read
Findings from this study in the two patients show that MSC infusion in kidney transplant recipients is feasible, allows enlargement of Treg in the peripheral blood, and controls memory CD8+ T cell function. Future clinical trials with MSCs to look with the greatest care for unwanted side effects is advised.
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.